Diagnostic power and clinical impact of exome sequencing in a cohort of 500 patients with rare diseases
Caio Robledo D’Angioli Costa Quaio(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Chong Ae Kim(AstraZeneca (United States)), Gil Monteiro Novo Filho(Fleury S.A. (Brazil)), Caroline Mônaco Moreira(Fleury S.A. (Brazil)), Rodrigo Fernandes Ramalho(Fleury S.A. (Brazil)), Rafael Alves da Silva, Sandro Félix Perazzio(Fleury S.A. (Brazil)), Michele Groenner Penna(Fleury S.A. (Brazil)), Wagner Antonio da Rosa Baratela(Fleury S.A. (Brazil)), Miguel Mitne‐Neto(Hospital Santa Paula), Patricia Rossi Sacramento-Bobo, Aurélio Pimenta Dutra(Fleury S.A. (Brazil)), Rafaela Rogerio Floriano de Sousa(Fleury S.A. (Brazil))
Cited by 2
Related Papers
A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis
|The American Journal of Human Genetics|2004|990
Rare variants in <i>SOS2</i> and <i>LZTR1</i> are associated with Noonan syndrome
|Journal of Medical Genetics|2015|245
Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients
|Human Molecular Genetics|2011|213
Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation
|The American Journal of Human Genetics|2019|136